Abel Hall LLC’s Elevation Oncology ELEV Stock Holding History

Abel Hall LLC’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-32,799	Closed	-$12K	–	339
2025 Q2	$12K	Buy	+32,799	New	+$10.9K	0.01%	281

Other funds holding ELEV

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Abel Hall LLC's ELEV Position: Q3 2025 in Review

Abel Hall LLC sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 32,799 shares — an estimated $12K sold.

Abel Hall LLC first reported a position in ELEV in Q2 2025 and held it in 1 quarter. The position peaked at $12K in Q2 2025. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

Abel Hall LLC reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
Abel Hall LLC sold 32,799 Elevation Oncology shares in Q3 2025, an estimated $12K.
Abel Hall LLC first reported a position in Elevation Oncology in Q2 2025 and held it in 1 quarter.
Abel Hall LLC's Elevation Oncology position peaked at $12K in Q2 2025.
1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on Abel Hall LLC's 13F filing for Q3 2025, filed 17 Nov 2025.